h-header

news

News dal mondo

02

Dic

Lonza sells Micro-Macinazione site in Switzerland to CDMO Microsize and Schedio Group

Microsize, a U.S.-based contract development and manufacturing organization (CDMO) specializing in particle size reduction and control technologies, has signed an agreement to acquire from Lonza its Micro-Macinazione (Mic Mac) dedicated micronization facility in Monteggio, Switzerland.

Under the deal for an undisclosed amount, Schedio Group — a Swiss-based provider of jet mills, isolators, spray dryers, and engineering services — is also investing with Microsize to strengthen and localize its operational base in Europe, according to the announcement. Both companies will invest in Mic Mac to boost its capabilities and hasten modernization...[PharmaManufacturing]

12

Dic

EMA finalizes guideline on developing and manufacturing synthetic peptides

EMA has published a final guideline on synthetic peptide development and manufacture. The text will take...

12

Dic

Riforma farmaceutica EU: Parlamento e Consiglio UE hanno trovato l'intesa

Parlamento e Consiglio UE hanno trovato l'intesa sulla riforma farmaceutica: un nuovo sistema di...

12

Dic

Riforma legislazione farmaceutica UE: reazioni contrastanti tra innovazione e accesso

L’accordo raggiunto tra Parlamento europeo, Consiglio e Commissione UE segna una svolta per la...

12

Dic

Legislazione farmaceutica EU: Accordo sulla riforma

Consiglio e Parlamento europeo hanno raggiunto un accordo provvisorio sulla revisione del quadro politico...

slider-banner

h-footer